Moreover, the insertion of the granulocyte-macrophage colony-stimulating factor (GM-CSF) gene into the viral genome enables Pexa-Vec to induce GM-CSF release after infecting tumor cells, thereby activating the host immune system against tumors. This evidence concerns the gene CSF2 and neoplasm.